Prostate Cancer & Exercise Research

New weapon against prostate cancer Did you know everyday more than 45 men are diagnosed with prostate cancer in Australia? Exercise is being teamed up with drug therapy to see if it can become a potent weapon against prostate cancer. EX-HEART trial Everyday more than 45 men are diagnosed with prostate cancer in Australia. Baker Institute EX-HEART Trial Androgen Deprivation Therapy (ADT) is a potent anti-cancer therapy that reduces prostate cancer mortality. However, ADT may increase the risk of cardiovascular morbidity and mortality. The purpose of this research study is to evaluate the impact of ADT on cardiovascular structure and function, as well as the impact of exercise training during ADT on cardiovascular structure and function. Participate in the trial with Baker Institute Who can participate? Men 40 years or older. Diagnosed with prostate cancer. Scheduled or within one-month of receiving ADT. Benefits of participation? Comprehensive cardiovascular screening including echocardiography, cardiac magnetic resonance imaging and cardiopulmonary exercise test. 3-month best practice exercise intervention. Supervised by an accredited exercise physiologist who specialises in prostate cancer. Individualised exercise prescriptions. Small group exercise sessions. Delivered at one of four fitness centres around Melbourne. All screening and training is provided free of charge to participants. All participants will receive the exercise intervention with the control group offered a delayed intervention (wait list control). Contact Baker Institute if you are interested If you are interested in participating or would like further information, please contact Baker Institute: Ashley Bigaran T 03 8532 1108 E Ashley.Bigaran@baker.edu.au Contact Moonee Valley Health and Fitness Our Melbourne clinic is based at 378 Mount Alexander Road, Travancore [...]